25 XP   0   0   10

Pacific Biosciences of California
Buy, Hold or Sell?

Let's analyse Pacific Biosciences of California together

PenkeI guess you are interested in Pacific Biosciences of California. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pacific Biosciences of California. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pacific Biosciences of California

I send you an email if I find something interesting about Pacific Biosciences of California.

Quick analysis of Pacific Biosciences of California (30 sec.)










What can you expect buying and holding a share of Pacific Biosciences of California? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.62
Expected worth in 1 year
$3.13
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$0.52
Return On Investment
35.4%

For what price can you sell your share?

Current Price per Share
$1.46
Expected price per share
$0 - $3.85
How sure are you?
50%

1. Valuation of Pacific Biosciences of California (5 min.)




Live pricePrice per Share (EOD)

$1.46

Intrinsic Value Per Share

$-14.10 - $-6.22

Total Value Per Share

$-11.48 - $-3.60

2. Growth of Pacific Biosciences of California (5 min.)




Is Pacific Biosciences of California growing?

Current yearPrevious yearGrowGrow %
How rich?$701.3m$651.4m$48.3m6.9%

How much money is Pacific Biosciences of California making?

Current yearPrevious yearGrowGrow %
Making money-$74.9m-$79.3m$4.3m5.8%
Net Profit Margin-154.0%-250.2%--

How much money comes from the company's main activities?

3. Financial Health of Pacific Biosciences of California (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#45 / 339

Most Revenue
#115 / 339

Most Profit
#328 / 339

Most Efficient
#265 / 339

What can you expect buying and holding a share of Pacific Biosciences of California? (5 min.)

Welcome investor! Pacific Biosciences of California's management wants to use your money to grow the business. In return you get a share of Pacific Biosciences of California.

What can you expect buying and holding a share of Pacific Biosciences of California?

First you should know what it really means to hold a share of Pacific Biosciences of California. And how you can make/lose money.

Speculation

The Price per Share of Pacific Biosciences of California is $1.46. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pacific Biosciences of California.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pacific Biosciences of California, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.62. Based on the TTM, the Book Value Change Per Share is $0.13 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pacific Biosciences of California.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.31-21.0%-0.29-19.6%-0.29-20.1%-0.16-11.0%-0.11-7.8%
Usd Book Value Change Per Share-0.23-16.0%0.138.8%-0.21-14.6%0.117.5%0.064.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.23-16.0%0.138.8%-0.21-14.6%0.117.5%0.064.0%
Usd Price Per Share9.81-10.76-6.88-12.54-9.17-
Price to Earnings Ratio-8.01--9.49--5.79--187.02--114.59-
Price-to-Total Gains Ratio-42.10--17.70--32.07--30.20--2.45-
Price to Book Ratio3.75-4.18-2.86-14.12-18.07-
Price-to-Total Gains Ratio-42.10--17.70--32.07--30.20--2.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.46
Number of shares684
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.130.11
Usd Total Gains Per Share0.130.11
Gains per Quarter (684 shares)88.3274.95
Gains per Year (684 shares)353.29299.81
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103533430300290
207076960600590
30106010490899890
4014131402011991190
5017661755014991490
6021202108017991790
7024732461020992090
8028262814023982390
9031803167026982690
10035333520029982990

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%4.036.00.010.0%4.054.01.06.8%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%7.013.00.035.0%16.024.00.040.0%19.038.02.032.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.059.00.0%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%7.013.00.035.0%16.024.00.040.0%19.038.02.032.2%

Fundamentals of Pacific Biosciences of California

About Pacific Biosciences of California

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Fundamental data was last updated by Penke on 2024-04-12 14:31:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pacific Biosciences of California.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pacific Biosciences of California earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pacific Biosciences of California to the Medical Devices industry mean.
  • A Net Profit Margin of -140.5% means that $-1.41 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pacific Biosciences of California:

  • The MRQ is -140.5%. The company is making a huge loss. -2
  • The TTM is -154.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-140.5%TTM-154.0%+13.5%
TTM-154.0%YOY-250.2%+96.2%
TTM-154.0%5Y-129.5%-24.5%
5Y-129.5%10Y-112.2%-17.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-140.5%-11.2%-129.3%
TTM-154.0%-19.6%-134.4%
YOY-250.2%-14.4%-235.8%
5Y-129.5%-21.3%-108.2%
10Y-112.2%-24.8%-87.4%
1.1.2. Return on Assets

Shows how efficient Pacific Biosciences of California is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pacific Biosciences of California to the Medical Devices industry mean.
  • -4.7% Return on Assets means that Pacific Biosciences of California generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pacific Biosciences of California:

  • The MRQ is -4.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.7%TTM-4.1%-0.6%
TTM-4.1%YOY-4.3%+0.2%
TTM-4.1%5Y-4.9%+0.8%
5Y-4.9%10Y-8.8%+4.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.7%-4.0%-0.7%
TTM-4.1%-4.5%+0.4%
YOY-4.3%-4.8%+0.5%
5Y-4.9%-4.0%-0.9%
10Y-8.8%-5.2%-3.6%
1.1.3. Return on Equity

Shows how efficient Pacific Biosciences of California is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pacific Biosciences of California to the Medical Devices industry mean.
  • -11.7% Return on Equity means Pacific Biosciences of California generated $-0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pacific Biosciences of California:

  • The MRQ is -11.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.7%TTM-10.8%-0.9%
TTM-10.8%YOY-12.3%+1.5%
TTM-10.8%5Y-15.9%+5.1%
5Y-15.9%10Y-19.7%+3.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.7%-3.9%-7.8%
TTM-10.8%-5.6%-5.2%
YOY-12.3%-5.9%-6.4%
5Y-15.9%-6.1%-9.8%
10Y-19.7%-7.1%-12.6%

1.2. Operating Efficiency of Pacific Biosciences of California.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pacific Biosciences of California is operating .

  • Measures how much profit Pacific Biosciences of California makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pacific Biosciences of California to the Medical Devices industry mean.
  • An Operating Margin of -178.6% means the company generated $-1.79  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pacific Biosciences of California:

  • The MRQ is -178.6%. The company is operating very inefficient. -2
  • The TTM is -171.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-178.6%TTM-171.1%-7.6%
TTM-171.1%YOY-240.8%+69.7%
TTM-171.1%5Y-165.2%-5.9%
5Y-165.2%10Y-133.8%-31.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-178.6%-22.8%-155.8%
TTM-171.1%-17.1%-154.0%
YOY-240.8%-13.4%-227.4%
5Y-165.2%-19.2%-146.0%
10Y-133.8%-24.0%-109.8%
1.2.2. Operating Ratio

Measures how efficient Pacific Biosciences of California is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 2.48 means that the operating costs are $2.48 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pacific Biosciences of California:

  • The MRQ is 2.480. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.583. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.480TTM2.583-0.103
TTM2.583YOY3.408-0.825
TTM2.5835Y2.587-0.004
5Y2.58710Y2.292+0.295
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4801.428+1.052
TTM2.5831.426+1.157
YOY3.4081.503+1.905
5Y2.5871.440+1.147
10Y2.2921.371+0.921

1.3. Liquidity of Pacific Biosciences of California.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pacific Biosciences of California is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 7.81 means the company has $7.81 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pacific Biosciences of California:

  • The MRQ is 7.809. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.512. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.809TTM11.512-3.703
TTM11.512YOY12.869-1.357
TTM11.5125Y10.684+0.827
5Y10.68410Y7.688+2.996
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.8092.787+5.022
TTM11.5122.763+8.749
YOY12.8693.488+9.381
5Y10.6843.617+7.067
10Y7.6883.514+4.174
1.3.2. Quick Ratio

Measures if Pacific Biosciences of California is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pacific Biosciences of California to the Medical Devices industry mean.
  • A Quick Ratio of 11.78 means the company can pay off $11.78 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pacific Biosciences of California:

  • The MRQ is 11.784. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 18.237. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.784TTM18.237-6.453
TTM18.237YOY19.306-1.069
TTM18.2375Y15.569+2.668
5Y15.56910Y10.964+4.605
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ11.7841.539+10.245
TTM18.2371.660+16.577
YOY19.3062.139+17.167
5Y15.5692.300+13.269
10Y10.9642.255+8.709

1.4. Solvency of Pacific Biosciences of California.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pacific Biosciences of California assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pacific Biosciences of California to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.60 means that Pacific Biosciences of California assets are financed with 59.8% credit (debt) and the remaining percentage (100% - 59.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pacific Biosciences of California:

  • The MRQ is 0.598. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.621. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.598TTM0.621-0.023
TTM0.621YOY0.649-0.028
TTM0.6215Y0.624-0.003
5Y0.62410Y0.531+0.092
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5980.389+0.209
TTM0.6210.386+0.235
YOY0.6490.338+0.311
5Y0.6240.442+0.182
10Y0.5310.460+0.071
1.4.2. Debt to Equity Ratio

Measures if Pacific Biosciences of California is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pacific Biosciences of California to the Medical Devices industry mean.
  • A Debt to Equity ratio of 149.0% means that company has $1.49 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pacific Biosciences of California:

  • The MRQ is 1.490. The company is able to pay all its debts with equity. +1
  • The TTM is 1.648. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.490TTM1.648-0.159
TTM1.648YOY1.857-0.209
TTM1.6485Y1.932-0.284
5Y1.93210Y1.397+0.535
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4900.559+0.931
TTM1.6480.560+1.088
YOY1.8570.478+1.379
5Y1.9320.624+1.308
10Y1.3970.674+0.723

2. Market Valuation of Pacific Biosciences of California

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pacific Biosciences of California generates.

  • Above 15 is considered overpriced but always compare Pacific Biosciences of California to the Medical Devices industry mean.
  • A PE ratio of -8.01 means the investor is paying $-8.01 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pacific Biosciences of California:

  • The EOD is -1.192. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.012. Based on the earnings, the company is expensive. -2
  • The TTM is -9.487. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.192MRQ-8.012+6.820
MRQ-8.012TTM-9.487+1.475
TTM-9.487YOY-5.794-3.693
TTM-9.4875Y-187.020+177.533
5Y-187.02010Y-114.591-72.429
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.192-1.037-0.155
MRQ-8.012-1.578-6.434
TTM-9.487-2.041-7.446
YOY-5.794-2.971-2.823
5Y-187.020-2.058-184.962
10Y-114.591-1.463-113.128
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pacific Biosciences of California:

  • The EOD is -1.640. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -11.020. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -11.905. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.640MRQ-11.020+9.380
MRQ-11.020TTM-11.905+0.885
TTM-11.905YOY-6.523-5.382
TTM-11.9055Y-31.372+19.467
5Y-31.37210Y-40.539+9.167
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.640-1.007-0.633
MRQ-11.020-1.544-9.476
TTM-11.905-3.018-8.887
YOY-6.523-6.339-0.184
5Y-31.372-4.928-26.444
10Y-40.539-4.950-35.589
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pacific Biosciences of California is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 3.75 means the investor is paying $3.75 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pacific Biosciences of California:

  • The EOD is 0.558. Based on the equity, the company is cheap. +2
  • The MRQ is 3.748. Based on the equity, the company is fair priced.
  • The TTM is 4.178. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD0.558MRQ3.748-3.190
MRQ3.748TTM4.178-0.430
TTM4.178YOY2.859+1.319
TTM4.1785Y14.119-9.941
5Y14.11910Y18.074-3.955
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.5581.987-1.429
MRQ3.7482.379+1.369
TTM4.1782.444+1.734
YOY2.8593.215-0.356
5Y14.1193.833+10.286
10Y18.0744.163+13.911
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Pacific Biosciences of California.

3.1. Institutions holding Pacific Biosciences of California

Institutions are holding 101.756% of the shares of Pacific Biosciences of California.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31ARK Investment Management LLC12.8772.00434504273468183315.699
2023-12-31Vanguard Group Inc9.99790.005726789552351479215.1013
2023-12-31BlackRock Inc9.19670.00622464266619661608.6705
2023-12-31Madrone Advisors LLC6.565321.50081759191511759827.1637
2023-12-31Nikko Asset Management Americas Inc4.92641.246113200375-247291-1.8389
2023-12-31Sumitomo Mitsui Trust Holdings Inc4.92640.095713200375-247291-1.8389
2023-12-31Morgan Stanley - Brokerage Accounts4.14610.0096111095828824381386.1534
2023-12-31Jackson Square Partners, LLC3.62183.09379704766277090139.9619
2023-12-31T. Rowe Price Investment Management,Inc.2.89370.049577537813382574.5615
2023-12-31Bellevue Group AG2.73081.0987317128719400.9929
2023-12-31Deep Track Capital, LP2.61242.29337000000100000016.6667
2023-12-31Farallon Capital Management, L.L.C.2.31060.30156191370-4032750-39.4435
2023-12-31State Street Corporation2.0990.002756243292524474.6994
2023-12-31Geode Capital Management, LLC2.05870.005755163864121508.0747
2023-12-31Macquarie Group Ltd1.85540.0563497150472378517.0394
2023-12-31Bank of New York Mellon Corp1.82590.0097489243848963911.1211
2023-12-31FMR Inc1.39020.00283725054-897866-19.4221
2023-12-31T. Rowe Price Associates, Inc.1.34330.00473599275-389435-9.7634
2023-12-31Capital World Investors1.26520.0059339000000
2023-12-31Goldman Sachs Group Inc1.18760.00283182214148882187.9194
Total 79.830431.7947213906983+21896455+10.2%

3.2. Funds holding Pacific Biosciences of California

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28ARK Innovation ETF7.29530.94319547912-112870-0.5741
2024-03-31ARK Disruptive Innovation Full Composite7.27650.941619497504-59741-0.3055
2024-03-31ARK Genomic Revolution4.32062.701411577138-1451516-11.141
2024-03-28ARK Genomic Revolution ETF4.3092.7026115460971090.0009
2024-02-29Vanguard Total Stock Mkt Idx Inv3.12710.0038379029-216718-2.5212
2024-02-29Nikko AM ARK Pstv Chg Innovt P JPY Acc2.70651.59157252117-49764-0.6815
2024-02-29Vanguard Small Cap Index2.57250.02716892994644430.9437
2023-12-31American Funds SMALLCAP World A2.42720.0887650374900
2024-03-28iShares Russell 2000 ETF2.29130.0352613966929610.0483
2024-02-29Delaware Small Cap Core I2.06010.4147552014315480.0281
2023-11-30Bellevue Healthcare Ord1.99315.14335340649-3426813-39.0856
2024-02-29Nikko AM ARK Disruptive Innovation A USD1.83940.8809492859600
2024-02-29EdRF Big Data N EUR1.75931.204647140672547928117.6253
2024-02-29Vanguard Small Cap Value Index Inv1.75120.04884692401194750.4168
2023-12-31Macquarie US Small Cap Core Equity1.52250.5354407968959904217.2107
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.380.02369779825390.0687
2023-12-31T. Rowe Price Small-Cap Stock1.21440.33743254120-4800-0.1473
2023-12-31T. Rowe Price US Small-Cap Core Equity1.21440.33653254120-4800-0.1473
2023-12-31T. Rowe Price Health Sciences1.00240.17912685929-351596-11.5751
2024-01-31Fidelity Small Cap Index0.95150.06692549480425781.6984
Total 53.014318.2017142053201-2397995-1.7%

3.3. Insider Transactions

Insiders are holding 2.798% of the shares of Pacific Biosciences of California.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-06David W MelineBUY400004.4
2024-03-04Michele FarmerSELL29684.87
2024-02-20Susan G KimSELL8315.26
2024-02-16Oene Mark VanSELL335605.96
2024-01-09Oene Mark VanSELL310127.77
2023-12-14Christian O HenrySELL2000010
2023-09-29Susan G KimSELL192578.44
2023-09-18Christian O HenrySELL9684410.12
2023-09-11Christian O HenrySELL1000010.45
2023-05-18Michele FarmerSELL516512.59

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Pacific Biosciences of California compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2330.129-280%-0.213-9%0.110-313%0.059-495%
Book Value Per Share--2.6172.612+0%2.431+8%1.571+67%0.937+179%
Current Ratio--7.80911.512-32%12.869-39%10.684-27%7.688+2%
Debt To Asset Ratio--0.5980.621-4%0.649-8%0.624-4%0.531+13%
Debt To Equity Ratio--1.4901.648-10%1.857-20%1.932-23%1.397+7%
Dividend Per Share----0%-0%-0%-0%
Eps---0.306-0.286-7%-0.293-4%-0.160-48%-0.114-63%
Free Cash Flow Per Share---0.223-0.250+12%-0.261+17%-0.136-39%-0.098-56%
Free Cash Flow To Equity Per Share---0.527-0.148-72%-0.252-52%0.156-437%0.078-778%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---6.219--------
Intrinsic Value_10Y_min---14.101--------
Intrinsic Value_1Y_max---0.427--------
Intrinsic Value_1Y_min---0.933--------
Intrinsic Value_3Y_max---1.433--------
Intrinsic Value_3Y_min---3.236--------
Intrinsic Value_5Y_max---2.619--------
Intrinsic Value_5Y_min---5.995--------
Market Cap391209920.000-572%2628609120.0002883163520.000-9%1842839880.000+43%3359314224.000-22%2456717912.000+7%
Net Profit Margin---1.405-1.540+10%-2.502+78%-1.295-8%-1.122-20%
Operating Margin---1.786-1.711-4%-2.408+35%-1.652-8%-1.338-25%
Operating Ratio--2.4802.583-4%3.408-27%2.587-4%2.292+8%
Pb Ratio0.558-572%3.7484.178-10%2.859+31%14.119-73%18.074-79%
Pe Ratio-1.192+85%-8.012-9.487+18%-5.794-28%-187.020+2234%-114.591+1330%
Price Per Share1.460-572%9.81010.760-9%6.878+43%12.537-22%9.169+7%
Price To Free Cash Flow Ratio-1.640+85%-11.020-11.905+8%-6.523-41%-31.372+185%-40.539+268%
Price To Total Gains Ratio-6.265+85%-42.099-17.704-58%-32.068-24%-30.202-28%-2.445-94%
Quick Ratio--11.78418.237-35%19.306-39%15.569-24%10.964+7%
Return On Assets---0.047-0.041-13%-0.043-9%-0.049+3%-0.088+88%
Return On Equity---0.117-0.108-8%-0.123+5%-0.159+36%-0.197+68%
Total Gains Per Share---0.2330.129-280%-0.213-9%0.110-313%0.059-495%
Usd Book Value--701304000.000699790750.000+0%651489750.000+8%420951550.000+67%250941875.000+179%
Usd Book Value Change Per Share---0.2330.129-280%-0.213-9%0.110-313%0.059-495%
Usd Book Value Per Share--2.6172.612+0%2.431+8%1.571+67%0.937+179%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.306-0.286-7%-0.293-4%-0.160-48%-0.114-63%
Usd Free Cash Flow---59634000.000-67016500.000+12%-70035000.000+17%-36400050.000-39%-26358650.000-56%
Usd Free Cash Flow Per Share---0.223-0.250+12%-0.261+17%-0.136-39%-0.098-56%
Usd Free Cash Flow To Equity Per Share---0.527-0.148-72%-0.252-52%0.156-437%0.078-778%
Usd Market Cap391209920.000-572%2628609120.0002883163520.000-9%1842839880.000+43%3359314224.000-22%2456717912.000+7%
Usd Price Per Share1.460-572%9.81010.760-9%6.878+43%12.537-22%9.169+7%
Usd Profit---82018000.000-74967000.000-9%-79308750.000-3%-42652850.000-48%-30500975.000-63%
Usd Revenue--58357000.00050130250.000+16%32076000.000+82%31456100.000+86%26132650.000+123%
Usd Total Gains Per Share---0.2330.129-280%-0.213-9%0.110-313%0.059-495%
 EOD+3 -5MRQTTM+13 -20YOY+18 -155Y+11 -2210Y+12 -21

4.2. Fundamental Score

Let's check the fundamental score of Pacific Biosciences of California based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.192
Price to Book Ratio (EOD)Between0-10.558
Net Profit Margin (MRQ)Greater than0-1.405
Operating Margin (MRQ)Greater than0-1.786
Quick Ratio (MRQ)Greater than111.784
Current Ratio (MRQ)Greater than17.809
Debt to Asset Ratio (MRQ)Less than10.598
Debt to Equity Ratio (MRQ)Less than11.490
Return on Equity (MRQ)Greater than0.15-0.117
Return on Assets (MRQ)Greater than0.05-0.047
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Pacific Biosciences of California based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5018.117
Ma 20Greater thanMa 503.163
Ma 50Greater thanMa 1004.322
Ma 100Greater thanMa 2006.273
OpenGreater thanClose1.390
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -4,7652,841-1,924-762-2,686846-1,8402,059219
Long-term Assets Other  10,5282,79113,319-17613,143-13913,004-456,714-443,710



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,746,013
Total Liabilities1,044,709
Total Stockholder Equity701,304
 As reported
Total Liabilities 1,044,709
Total Stockholder Equity+ 701,304
Total Assets = 1,746,013

Assets

Total Assets1,746,013
Total Current Assets742,047
Long-term Assets1,003,966
Total Current Assets
Cash And Cash Equivalents 180,211
Short-term Investments 451,505
Net Receivables 36,615
Inventory 56,676
Other Current Assets 17,040
Total Current Assets  (as reported)742,047
Total Current Assets  (calculated)742,047
+/-0
Long-term Assets
Property Plant Equipment 69,025
Goodwill 462,261
Intangible Assets 456,984
Other Assets 0
Long-term Assets  (as reported)1,003,966
Long-term Assets  (calculated)988,270
+/- 15,696

Liabilities & Shareholders' Equity

Total Current Liabilities95,029
Long-term Liabilities949,680
Total Stockholder Equity701,304
Total Current Liabilities
Short-term Debt 10,081
Short Long Term Debt 490
Accounts payable 15,062
Other Current Liabilities 53,544
Total Current Liabilities  (as reported)95,029
Total Current Liabilities  (calculated)79,177
+/- 15,852
Long-term Liabilities
Long term Debt 892,243
Capital Lease Obligations 41,197
Long-term Liabilities Other 20,301
Long-term Liabilities  (as reported)949,680
Long-term Liabilities  (calculated)953,741
+/- 4,061
Total Stockholder Equity
Common Stock268
Retained Earnings -1,839,075
Accumulated Other Comprehensive Income 219
Other Stockholders Equity 2,539,892
Total Stockholder Equity (as reported)701,304
Total Stockholder Equity (calculated)701,304
+/-0
Other
Capital Stock268
Cash and Short Term Investments 631,716
Common Stock Shares Outstanding 267,121
Current Deferred Revenue16,342
Liabilities and Stockholders Equity 1,746,013
Net Debt 753,719
Net Invested Capital 1,594,037
Net Working Capital 647,018
Property Plant and Equipment Gross 143,819
Short Long Term Debt Total 933,930



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302008-12-31
> Total Assets 
113,107
0
101,098
0
152,897
129,936
305,747
278,558
261,220
237,961
218,316
194,738
169,930
148,208
129,683
139,774
134,277
152,800
136,185
141,040
128,241
121,642
124,523
106,421
96,770
99,777
131,107
140,175
161,371
150,635
137,884
135,508
177,905
157,904
144,084
156,949
137,058
182,906
170,275
185,577
170,582
146,110
147,985
234,764
213,648
300,318
413,980
1,252,888
1,245,781
2,034,155
2,006,970
1,936,666
1,876,142
1,818,949
1,767,086
1,896,417
1,847,631
1,898,354
1,746,013
1,746,0131,898,3541,847,6311,896,4171,767,0861,818,9491,876,1421,936,6662,006,9702,034,1551,245,7811,252,888413,980300,318213,648234,764147,985146,110170,582185,577170,275182,906137,058156,949144,084157,904177,905135,508137,884150,635161,371140,175131,10799,77796,770106,421124,523121,642128,241141,040136,185152,800134,277139,774129,683148,208169,930194,738218,316237,961261,220278,558305,747129,936152,8970101,0980113,107
   > Total Current Assets 
0
0
93,745
0
140,007
117,286
293,114
264,270
244,728
220,283
199,601
176,806
152,643
132,338
115,000
126,481
122,114
141,763
126,459
132,062
119,898
114,137
117,760
99,522
90,189
86,207
110,541
119,053
138,055
122,467
109,011
88,340
132,932
113,611
101,619
115,699
96,412
143,873
131,659
112,588
98,909
76,941
81,046
169,530
150,939
239,508
354,751
1,199,452
1,192,136
1,134,365
1,105,726
1,034,170
973,209
916,818
854,996
984,033
937,974
884,719
742,047
742,047884,719937,974984,033854,996916,818973,2091,034,1701,105,7261,134,3651,192,1361,199,452354,751239,508150,939169,53081,04676,94198,909112,588131,659143,87396,412115,699101,619113,611132,93288,340109,011122,467138,055119,053110,54186,20790,18999,522117,760114,137119,898132,062126,459141,763122,114126,481115,000132,338152,643176,806199,601220,283244,728264,270293,114117,286140,007093,74500
       Cash And Cash Equivalents 
78,462
0
89,232
0
90,144
62,717
147,650
84,615
54,514
57,580
58,865
56,260
33,623
32,558
46,540
53,038
106,968
126,936
26,362
118,736
28,200
35,411
36,449
30,271
25,930
58,909
82,270
91,531
24,778
22,794
16,765
28,982
36,478
25,931
62,872
25,458
23,058
115,747
18,844
38,205
30,358
33,084
49,099
142,591
119,963
208,550
318,814
932,398
459,794
425,388
460,725
428,574
310,445
304,433
325,089
353,834
209,287
-43,560
180,211
180,211-43,560209,287353,834325,089304,433310,445428,574460,725425,388459,794932,398318,814208,550119,963142,59149,09933,08430,35838,20518,844115,74723,05825,45862,87225,93136,47828,98216,76522,79424,77891,53182,27058,90925,93030,27136,44935,41128,200118,73626,362126,936106,96853,03846,54032,55833,62356,26058,86557,58054,51484,615147,65062,71790,144089,232078,462
       Short-term Investments 
27,589
0
3,503
0
48,612
50,215
136,024
163,933
162,074
136,116
118,569
105,089
103,485
86,844
54,040
59,267
66,135
62,169
86,166
77,475
76,834
63,901
64,899
48,878
46,744
31,701
48,641
71,451
77,692
64,539
55,213
27,068
66,118
58,034
46,365
53,802
40,433
77,684
83,510
44,667
36,486
16,120
19,472
73,729
76,621
139,522
237,203
227,921
684,579
654,502
583,675
534,201
588,706
529,907
447,229
521,058
620,575
811,349
451,505
451,505811,349620,575521,058447,229529,907588,706534,201583,675654,502684,579227,921237,203139,52276,62173,72919,47216,12036,48644,66783,51077,68440,43353,80246,36558,03466,11827,06855,21364,53977,69271,45148,64131,70146,74448,87864,89963,90176,83477,47586,16662,16966,13559,26754,04086,844103,485105,089118,569136,116162,074163,933136,02450,21548,61203,503027,589
       Net Receivables 
0
0
0
0
0
1,052
341
59
5,437
4,434
4,557
1,505
3,371
532
2,822
2,009
4,104
3,814
2,746
3,383
4,255
2,370
3,406
5,287
3,950
4,164
5,245
8,009
10,427
11,761
16,421
10,441
9,525
8,897
13,433
8,452
7,446
6,404
8,595
7,279
12,123
9,966
15,266
7,325
11,346
11,806
16,837
12,906
19,936
23,946
24,241
27,852
27,058
22,756
18,786
29,589
24,034
30,486
36,615
36,61530,48624,03429,58918,78622,75627,05827,85224,24123,94619,93612,90616,83711,80611,3467,32515,2669,96612,1237,2798,5956,4047,4468,45213,4338,8979,52510,44116,42111,76110,4278,0095,2454,1643,9505,2873,4062,3704,2553,3832,7463,8144,1042,0092,8225323,3711,5054,5574,4345,437593411,05200000
       Inventory 
0
0
0
0
0
0
6,864
13,539
19,552
20,262
15,517
11,821
10,271
10,202
9,592
10,597
10,283
9,819
10,050
8,301
9,440
11,398
11,335
13,457
11,978
11,621
10,955
12,162
14,201
16,473
15,634
15,348
17,266
18,201
23,065
25,930
23,440
19,694
17,878
19,650
17,404
15,067
13,312
16,124
16,768
15,940
14,230
16,268
17,985
18,276
24,599
29,625
36,121
43,495
50,381
61,955
67,608
68,256
56,676
56,67668,25667,60861,95550,38143,49536,12129,62524,59918,27617,98516,26814,23015,94016,76816,12413,31215,06717,40419,65017,87819,69423,44025,93023,06518,20117,26615,34815,63416,47314,20112,16210,95511,62111,97813,45711,33511,3989,4408,30110,0509,81910,28310,5979,59210,20210,27111,82115,51720,26219,55213,5396,864000000
   > Long-term Assets 
0
0
7,353
0
12,890
12,650
12,633
14,288
16,492
17,678
18,715
17,932
17,287
15,870
14,683
13,293
12,163
11,037
9,726
8,978
8,343
7,505
6,763
6,899
6,581
13,570
20,566
21,122
23,316
28,168
28,873
47,168
44,973
44,293
42,465
41,250
40,646
39,033
38,616
72,989
71,673
69,169
66,939
65,234
62,709
60,810
59,229
53,436
53,645
899,790
901,244
902,496
902,933
902,131
912,090
912,384
909,657
1,013,635
1,003,966
1,003,9661,013,635909,657912,384912,090902,131902,933902,496901,244899,79053,64553,43659,22960,81062,70965,23466,93969,16971,67372,98938,61639,03340,64641,25042,46544,29344,97347,16828,87328,16823,31621,12220,56613,5706,5816,8996,7637,5058,3438,9789,72611,03712,16313,29314,68315,87017,28717,93218,71517,67816,49214,28812,63312,65012,89007,35300
       Property Plant Equipment 
6,027
0
7,142
0
12,669
12,350
12,311
13,932
16,180
17,359
18,398
17,592
16,937
15,514
14,329
12,779
11,655
10,544
9,236
8,492
7,861
7,034
6,601
6,743
6,428
7,855
8,548
9,093
11,188
14,003
14,560
42,449
40,289
39,605
37,920
36,704
36,103
34,490
34,073
68,424
67,632
65,128
62,897
61,194
59,168
57,268
54,850
53,369
53,580
76,981
79,121
80,431
81,231
80,687
81,343
79,080
76,761
74,950
69,025
69,02574,95076,76179,08081,34380,68781,23180,43179,12176,98153,58053,36954,85057,26859,16861,19462,89765,12867,63268,42434,07334,49036,10336,70437,92039,60540,28942,44914,56014,00311,1889,0938,5487,8556,4286,7436,6017,0347,8618,4929,23610,54411,65512,77914,32915,51416,93717,59218,39817,35916,18013,93212,31112,35012,66907,14206,027
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
411,533
409,974
409,974
409,974
409,974
409,974
409,974
409,974
463,843
462,261
462,261463,843409,974409,974409,974409,974409,974409,974409,974411,5330000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
411,206
410,979
410,751
410,523
410,294
410,245
410,011
409,779
461,838
456,984
456,984461,838409,779410,011410,245410,294410,523410,751410,979411,2060000000000000000000000000000000000000000000000000
       Long-term Assets Other 
0
0
211
0
221
300
322
356
312
319
317
340
350
356
354
514
508
493
490
486
482
471
162
156
153
5,715
12,018
12,029
12,128
14,165
14,313
4,719
4,684
4,688
4,545
4,546
4,543
4,543
4,543
4,565
4,041
4,041
4,042
4,040
3,541
3,542
4,379
67
65
70
1,170
1,340
1,205
1,176
10,528
13,319
13,143
13,004
-443,710
-443,71013,00413,14313,31910,5281,1761,2051,3401,1707065674,3793,5423,5414,0404,0424,0414,0414,5654,5434,5434,5434,5464,5454,6884,6844,71914,31314,16512,12812,02912,0185,715153156162471482486490493508514354356350340317319312356322300221021100
> Total Liabilities 
5,411
0
278,221
0
21,229
403,236
25,881
29,887
27,894
27,277
26,853
26,835
21,726
19,671
20,301
32,683
33,879
69,257
67,005
65,515
69,226
68,607
69,574
65,949
62,934
58,407
57,567
51,399
53,302
51,955
53,216
66,323
62,045
56,496
57,981
54,211
51,584
51,026
56,214
90,727
94,828
95,096
93,068
174,361
172,256
170,822
78,489
972,335
987,536
1,193,348
1,215,983
1,202,088
1,194,256
1,192,358
1,204,182
1,204,300
1,205,632
1,134,611
1,044,709
1,044,7091,134,6111,205,6321,204,3001,204,1821,192,3581,194,2561,202,0881,215,9831,193,348987,536972,33578,489170,822172,256174,36193,06895,09694,82890,72756,21451,02651,58454,21157,98156,49662,04566,32353,21651,95553,30251,39957,56758,40762,93465,94969,57468,60769,22665,51567,00569,25733,87932,68320,30119,67121,72626,83526,85327,27727,89429,88725,881403,23621,2290278,22105,411
   > Total Current Liabilities 
4,702
0
8,419
0
16,111
22,913
20,840
24,132
21,463
21,132
19,376
19,796
14,926
13,626
14,743
13,579
15,093
16,354
22,555
11,604
27,967
29,140
31,489
38,411
39,017
19,389
21,927
19,840
33,813
32,106
33,774
35,440
35,694
30,292
22,316
24,948
22,264
15,909
20,347
45,097
49,453
50,693
21,835
120,900
119,827
119,069
36,490
33,437
47,360
64,000
83,289
75,071
71,968
70,190
76,916
69,485
73,497
78,191
95,029
95,02978,19173,49769,48576,91670,19071,96875,07183,28964,00047,36033,43736,490119,069119,827120,90021,83550,69349,45345,09720,34715,90922,26424,94822,31630,29235,69435,44033,77432,10633,81319,84021,92719,38939,01738,41131,48929,14027,96711,60422,55516,35415,09313,57914,74313,62614,92619,79619,37621,13221,46324,13220,84022,91316,11108,41904,702
       Short-term Debt 
0
0
0
0
61
134
110
117
125
132
140
148
156
165
173
182
191
201
210
220
9,225
8,726
11,441
9,438
11,316
-9,346
-2,086
13
16,329
16,482
16,604
3,123
2,643
2,907
6,299
10,243
10,935
3,558
6,286
18,459
18,864
19,270
19,708
3,967
4,103
4,217
4,332
4,448
4,644
7,128
7,710
8,056
8,350
8,612
10,728
9,018
9,243
9,460
10,081
10,0819,4609,2439,01810,7288,6128,3508,0567,7107,1284,6444,4484,3324,2174,1033,96719,70819,27018,86418,4596,2863,55810,93510,2436,2992,9072,6433,12316,60416,48216,32913-2,086-9,34611,3169,43811,4418,7269,225220210201191182173165156148140132125117110134610000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,991
0
0
0
16,334
0
3,123
3,123
17,770
3,123
13,084
2,907
13,635
13,872
14,121
0
0
14,938
15,233
15,546
15,871
0
0
0
0
0
0
0
0
0
0
0
1,842
0
0
0
490
4900001,8420000000000015,87115,54615,23314,9380014,12113,87213,6352,90713,0843,12317,7703,1233,123016,33400013,9910000000000000000000000
       Accounts payable 
1,845
0
5,778
0
7,613
13,211
9,515
9,432
9,032
8,158
4,742
4,250
4,061
2,897
2,988
3,011
2,605
3,413
1,717
3,926
5,379
5,845
5,608
6,924
5,818
6,097
4,749
4,734
5,395
8,311
8,359
8,221
6,514
8,574
9,093
8,567
4,169
5,966
6,736
8,740
8,011
8,111
8,368
4,223
7,436
5,406
3,579
3,471
4,761
4,960
11,002
17,607
12,883
12,853
12,028
17,390
16,512
16,106
15,062
15,06216,10616,51217,39012,02812,85312,88317,60711,0024,9604,7613,4713,5795,4067,4364,2238,3688,1118,0118,7406,7365,9664,1698,5679,0938,5746,5148,2218,3598,3115,3954,7344,7496,0975,8186,9245,6085,8455,3793,9261,7173,4132,6053,0112,9882,8974,0614,2504,7428,1589,0329,4329,51513,2117,61305,77801,845
       Other Current Liabilities 
1,557
0
2,641
0
8,498
8,516
7,994
10,233
9,925
8,056
7,911
11,478
6,539
7,009
8,204
7,425
8,950
8,506
9,797
-3,231
1,304
2,477
1,534
1,410
991
1,950
1,627
1,462
1,422
742
1,681
17,413
19,755
12,660
605
145
744
645
788
11,470
15,871
16,933
-13,851
14,710
10,288
11,446
18,289
10,224
18,263
23,692
28,551
11,433
16,824
16,274
21,868
10,362
17,767
25,200
53,544
53,54425,20017,76710,36221,86816,27416,82411,43328,55123,69218,26310,22418,28911,44610,28814,710-13,85116,93315,87111,47078864574414560512,66019,75517,4131,6817421,4221,4621,6271,9509911,4101,5342,4771,304-3,2319,7978,5068,9507,4258,2047,0096,53911,4787,9118,0569,92510,2337,9948,5168,49802,64101,557
   > Long-term Liabilities 
0
0
269,802
0
5,118
380,323
5,041
5,755
6,431
6,145
7,477
7,039
6,800
6,045
5,558
19,104
18,786
52,903
44,450
53,911
41,259
39,467
38,085
27,538
23,917
39,018
35,640
31,559
19,489
19,849
19,442
30,883
26,351
26,204
35,665
29,263
29,320
35,117
35,867
45,630
45,375
44,403
71,233
53,461
52,429
51,753
41,999
938,898
940,176
1,129,348
1,132,694
1,127,017
1,122,288
1,122,168
1,127,266
1,134,815
1,132,135
1,056,420
949,680
949,6801,056,4201,132,1351,134,8151,127,2661,122,1681,122,2881,127,0171,132,6941,129,348940,176938,89841,99951,75352,42953,46171,23344,40345,37545,63035,86735,11729,32029,26335,66526,20426,35130,88319,44219,84919,48931,55935,64039,01823,91727,53838,08539,46741,25953,91144,45052,90318,78619,1045,5586,0456,8007,0397,4776,1456,4315,7555,041380,3235,1180269,80200
       Long term Debt Total 
0
0
0
0
0
0
0
0
2,861
2,824
2,786
2,747
2,705
2,659
2,613
0
13,007
13,173
13,347
13,525
13,714
13,914
14,124
14,339
14,567
14,808
14,948
15,216
15,496
15,794
16,106
13,302
10,441
10,456
13,635
13,872
14,121
14,384
14,659
0
0
0
0
0
0
0
0
895,674
895,762
895,915
896,067
896,220
896,374
896,529
0
896,839
891,795
0
0
00891,795896,8390896,529896,374896,220896,067895,915895,762895,6740000000014,65914,38414,12113,87213,63510,45610,44113,30216,10615,79415,49615,21614,94814,80814,56714,33914,12413,91413,71413,52513,34713,17313,00702,6132,6592,7052,7472,7862,8242,86100000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-61
-134
-110
-117
-125
-132
-140
-148
-156
-165
-173
-182
-191
-201
-210
-220
-9,225
-8,726
-11,441
-9,438
-11,316
9,346
2,086
-13
-16,329
-16,482
-16,604
-3,123
-2,643
-2,907
-6,299
-10,243
-10,935
-3,558
-6,286
29,923
28,688
27,422
26,093
40,903
39,863
38,793
37,667
36,485
35,431
49,954
49,970
47,740
45,497
43,163
39,228
38,969
36,599
34,100
31,116
31,11634,10036,59938,96939,22843,16345,49747,74049,97049,95435,43136,48537,66738,79339,86340,90326,09327,42228,68829,923-6,286-3,558-10,935-10,243-6,299-2,907-2,643-3,123-16,604-16,482-16,329-132,0869,346-11,316-9,438-11,441-8,726-9,225-220-210-201-191-182-173-165-156-148-140-132-125-117-110-134-610000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
3,570
3,321
3,075
0
0
2,386
2,145
0
2,513
2,458
3,517
2,345
2,847
2,505
2,153
2,192
2,192
1,323
1,386
1,462
1,532
1,605
1,683
1,741
0
0
0
0
0
0
0
45,630
45,375
44,403
43,915
42,387
41,394
40,554
39,987
42,924
4,339
176,351
178,947
244,858
172,067
173,864
180,627
41,787
42,428
120,864
20,301
20,301120,86442,42841,787180,627173,864172,067244,858178,947176,3514,33942,92439,98740,55441,39442,38743,91544,40345,37545,63000000001,7411,6831,6051,5321,4621,3861,3232,1922,1922,1532,5052,8472,3453,5172,4582,51302,1452,386003,0753,3213,57000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
1,616
1,443
0
1,000
800
0
3,266
31,147
27,586
27,132
24,698
23,048
21,808
11,007
7,158
3,522
3,055
2,711
2,461
2,450
1,653
15,840
15,910
15,748
15,711
15,391
15,199
14,993
14,671
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000014,67114,99315,19915,39115,71115,74815,91015,8401,6532,4502,4612,7113,0553,5227,15811,00721,80823,04824,69827,13227,58631,1473,26608001,00001,4431,6160000000000
> Total Stockholder Equity
107,696
0
-177,123
0
131,668
-273,300
279,866
248,671
233,326
210,684
191,463
167,903
148,204
128,537
109,382
107,091
100,398
83,543
69,180
75,525
59,015
53,035
54,949
40,472
33,836
41,370
73,540
88,776
108,069
98,680
84,668
69,185
115,860
101,408
86,103
102,738
85,474
131,880
114,061
94,850
75,754
51,014
54,917
60,403
41,392
129,496
335,491
280,553
258,245
840,807
790,987
734,578
681,886
626,591
562,904
692,117
641,999
763,743
701,304
701,304763,743641,999692,117562,904626,591681,886734,578790,987840,807258,245280,553335,491129,49641,39260,40354,91751,01475,75494,850114,061131,88085,474102,73886,103101,408115,86069,18584,66898,680108,06988,77673,54041,37033,83640,47254,94953,03559,01575,52569,18083,543100,398107,091109,382128,537148,204167,903191,463210,684233,326248,671279,866-273,300131,6680-177,1230107,696
   Common Stock
0
0
0
0
4
-297
53
53
54
55
55
636,903
639,751
642,822
645,372
664,204
677,995
681,614
684,479
70
71
71
74
75
75
76
80
87
91
93
93
94
116
116
116
132
132
149
150
153
153
153
153
154
154
180
192
198
199
221
221
224
225
226
227
250
250
258
268
26825825025022722622522422122119919819218015415415315315315315014913213211611611694939391878076757574717170684,479681,614677,995664,204645,372642,822639,751636,9035555545353-29740000
   Retained Earnings Total Equity00-1,690,188-1,620,3550-1,447,956-1,370,985-1,299,591-1,218,092-1,148,763-1,165,305-1,124,304-1,036,869-1,111,804-1,088,096-1,065,010-1,066,240-1,066,149-1,037,026-1,012,430-982,106-951,307-926,263-903,723-879,733-858,971-836,950-811,411-787,544-768,514-751,020-732,521-713,169-711,760-713,581-701,646-681,473-662,498-653,335-634,199-615,313-598,082-577,595-557,124-536,020-514,351-491,622-469,135-441,555-418,732-389,45100000000
   Accumulated Other Comprehensive Income 
0
0
1
0
-5
5
-21
3
181
-4
57
135
75
66
30
11
-2
11
14
18
42
23
9
16
12
6
-7
41
52
23
5
-3
-16
-2
-32
-38
-16
-24
-36
6
17
11
5
30
243
118
85
74
-6
27
-1,087
-4,085
-5,457
-6,260
-4,765
-1,924
-2,686
-1,840
219
219-1,840-2,686-1,924-4,765-6,260-5,457-4,085-1,08727-6748511824330511176-36-24-16-38-32-2-16-35235241-76121692342181411-21130667513557-41813-215-50100
   Capital Surplus 
0
0
0
0
0
0
0
0
622,542
629,365
0
0
0
0
0
0
0
0
684,413
709,636
712,237
715,439
736,339
742,027
747,330
753,048
786,636
821,169
858,946
867,078
872,114
880,505
952,710
960,265
965,752
1,006,367
1,011,621
1,083,062
1,096,053
1,107,121
1,112,610
1,116,999
1,120,999
1,125,229
1,129,091
1,241,002
1,372,083
1,404,585
1,423,357
1,989,322
2,009,945
2,038,030
2,058,103
2,080,581
0
2,314,146
2,334,623
0
0
002,334,6232,314,14602,080,5812,058,1032,038,0302,009,9451,989,3221,423,3571,404,5851,372,0831,241,0021,129,0911,125,2291,120,9991,116,9991,112,6101,107,1211,096,0531,083,0621,011,6211,006,367965,752960,265952,710880,505872,114867,078858,946821,169786,636753,048747,330742,027736,339715,439712,237709,636684,41300000000629,365622,54200000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
14,877
0
396,421
22,448
624,508
615,594
622,723
629,361
648,133
637,038
639,826
642,888
20,791
11
-2
11
710,676
709,654
712,279
715,462
766,805
742,043
747,342
753,054
820,494
821,210
858,998
867,101
909,148
918,642
984,807
993,315
997,914
1,006,329
1,011,605
1,083,038
1,133,124
1,107,127
1,112,627
1,117,010
1,165,222
1,125,259
1,129,334
1,241,002
335,406
1,404,585
1,423,357
1,989,322
792,074
2,038,030
2,058,103
2,080,581
2,099,782
2,314,146
2,334,623
2,522,382
2,539,892
2,539,8922,522,3822,334,6232,314,1462,099,7822,080,5812,058,1032,038,030792,0741,989,3221,423,3571,404,585335,4061,241,0021,129,3341,125,2591,165,2221,117,0101,112,6271,107,1271,133,1241,083,0381,011,6051,006,329997,914993,315984,807918,642909,148867,101858,998821,210820,494753,054747,342742,043766,805715,462712,279709,654710,67611-21120,791642,888639,826637,038648,133629,361622,723615,594624,50822,448396,421014,87700



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue200,521
Cost of Revenue-160,176
Gross Profit40,34540,345
 
Operating Income (+$)
Gross Profit40,345
Operating Expense-350,710
Operating Income-310,365-310,365
 
Operating Expense (+$)
Research Development187,170
Selling General Administrative168,825
Selling And Marketing Expenses0
Operating Expense350,710355,995
 
Net Interest Income (+$)
Interest Income0
Interest Expense-14,343
Other Finance Cost-77
Net Interest Income-14,420
 
Pretax Income (+$)
Operating Income-310,365
Net Interest Income-14,420
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-318,159-302,571
EBIT - interestExpense = -324,708
-318,159
-292,392
Interest Expense14,343
Earnings Before Interest and Taxes (EBIT)-310,365-303,816
Earnings Before Interest and Taxes (EBITDA)-277,674
 
After tax Income (+$)
Income Before Tax-318,159
Tax Provision--10,706
Net Income From Continuing Ops-309,101-307,453
Net Income-306,735
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses510,886
Total Other Income/Expenses Net-7,79414,420
 

Technical Analysis of Pacific Biosciences of California
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pacific Biosciences of California. The general trend of Pacific Biosciences of California is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pacific Biosciences of California's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pacific Biosciences of California.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.21 < 3.7 < 3.85.

The bearish price targets are: .

Tweet this
Pacific Biosciences of California Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pacific Biosciences of California. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pacific Biosciences of California Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pacific Biosciences of California. The current macd is -0.69223504.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pacific Biosciences of California price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pacific Biosciences of California. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pacific Biosciences of California price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Pacific Biosciences of California Daily Moving Average Convergence/Divergence (MACD) ChartPacific Biosciences of California Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pacific Biosciences of California. The current adx is 36.24.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pacific Biosciences of California shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Pacific Biosciences of California Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pacific Biosciences of California. The current sar is 3.33458075.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Pacific Biosciences of California Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pacific Biosciences of California. The current rsi is 18.12. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Pacific Biosciences of California Daily Relative Strength Index (RSI) ChartPacific Biosciences of California Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pacific Biosciences of California. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Pacific Biosciences of California price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Pacific Biosciences of California Daily Stochastic Oscillator ChartPacific Biosciences of California Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pacific Biosciences of California. The current cci is -217.96750759.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Pacific Biosciences of California Daily Commodity Channel Index (CCI) ChartPacific Biosciences of California Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pacific Biosciences of California. The current cmo is -72.46106547.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pacific Biosciences of California Daily Chande Momentum Oscillator (CMO) ChartPacific Biosciences of California Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pacific Biosciences of California. The current willr is -91.90751445.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Pacific Biosciences of California Daily Williams %R ChartPacific Biosciences of California Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pacific Biosciences of California.

Pacific Biosciences of California Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pacific Biosciences of California. The current atr is 0.37938952.

Pacific Biosciences of California Daily Average True Range (ATR) ChartPacific Biosciences of California Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pacific Biosciences of California. The current obv is -36,300,231.

Pacific Biosciences of California Daily On-Balance Volume (OBV) ChartPacific Biosciences of California Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pacific Biosciences of California. The current mfi is 23.60.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pacific Biosciences of California Daily Money Flow Index (MFI) ChartPacific Biosciences of California Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pacific Biosciences of California.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Pacific Biosciences of California Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pacific Biosciences of California based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5018.117
Ma 20Greater thanMa 503.163
Ma 50Greater thanMa 1004.322
Ma 100Greater thanMa 2006.273
OpenGreater thanClose1.390
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pacific Biosciences of California with someone you think should read this too:
  • Are you bullish or bearish on Pacific Biosciences of California? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pacific Biosciences of California? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pacific Biosciences of California

I send you an email if I find something interesting about Pacific Biosciences of California.


Comments

How you think about this?

Leave a comment

Stay informed about Pacific Biosciences of California.

Receive notifications about Pacific Biosciences of California in your mailbox!